HPLC method for the pharmacokinetics and tissue distribution of taspine solution and taspine liposome after intravenous administrations to mice

Journal of Pharmaceutical and Biomedical Analysis

Volumn 46, Issue 1, 2008, Pages 170-176

  Lu, Wen ^a   He, Lang Chong ^a   Zeng, Xian Ming ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

HPLC; Liposome; Pharmacokinetics; Taspine

Indexed keywords

APORPHINE DERIVATIVE; TASPINE LIPOSOME; TASPINE SOLUTION; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KIDNEY; LIVER; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; TISSUE DISTRIBUTION;

ALKALOIDS; ANIMALS; APORPHINES; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; FREEZE DRYING; HALF-LIFE; INJECTIONS, INTRAVENOUS; LIPOSOMES; MALE; METABOLIC CLEARANCE RATE; MICE; MICE, INBRED ICR; MOLECULAR STRUCTURE; SOLUBILITY; SOLUTIONS; TEMPERATURE; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 36749039649     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2007.08.009     Document Type: Article

References (21)

1. Perdue G.P., Blomster R.N., Blake D.A., and Arnsworth N.R. J. Pharm. Sci. 68 (1979) 124-126
2. Pieters L., De-Bruyne T., Claeys M., Vlietinck A., Calomme M., and Vanden B.D. J. Nat. Prod. 56 (1993) 899-906
3. Milanowski D.J., Winter R.E., Elv in-Lewis M.P., and Lewis W.H. J. Nat. Prod. 65 (2002) 814-819
4. Risco E., Ghia F., Vila R., Iglesias J., Alvarez E., and Canigueral S. Planta Med. 69 (2003) 785-794
5. Kennelly E.J., Flynn T.J., Mazzola E.P., Roach J.A., McCloud T.G., Danford D.E., and Betz J.M. J. Nat. Prod. 62 (1999) 1385-1389
6. Vaisberg A.J., Milla M., Planas M.C., Cordova J.L., De-Agusti E.R., Ferreyra R., Mustiga M.C., Carlin L., and Hammond G.B. Plant. Med. 55 (1989) 140-143
7. Porras-reyes B.H., Lweis W.H., Roman J., Simchwitz L., and Mustoe T.A. Proc. Soc. Exp. Biol. Med. 203 (1993) 18-25
8. Dong Y.L., He L.C., Wang H.H., You H.S., and Wu J.F. J. Chin. Int. Med. 3 (2005) 386-390
9. Itokawa H., Ichihara Y., Mochizuki M., Enomori T., Morita H., Shirota O., Inamatsu M., and Takeya K. Chem. Pharm. Bull. 39 (1991) 1041-1042
10. L.C. He, Y.P. Li, W. Lu, Y.M. Zhang, J. Zhang, Q. He, J. Du, J.F. Wu, China Patent, CN1800187A (2006).
11. Li Y.P., Qiang K., and He L.C. Chin. J. Pharm. Anal. 25 (2005) 1534-1536
12. Jia L., Garza M., Wong H., Reimer D., Redelmeier T., Camden J.B., and Weitman S.D. J. Pharm. Biomed. Anal. 28 (2002) 65-72
13. Kotwani R.N., Gokhale P.C., Bodhe P.V., Kirodian B.G., Kshirsagar N.A., and Pandya S.K. Int. J. Pharm. 238 (2002) 11-15
14. Immordino M.L., Brusa P., Arpicco S., Stella B., Dosio F., and Cattel L. J. Control. Release 91 (2003) 417-429
15. Guo W., Ahmad A., Khan S., Dahhani F., Wang Y.F., and Ahmad I. J. Chromatogr. B 791 (2003) 85-92
16. Guo W., Johnson J.L., Khan S., Ahmad A., and Ahmad I. Anal. Biochem. 336 (2005) 213-220
17. Khan S., Ahmad A., Guo W., Wang Y.F., Abu-Qare A., and Ahmad I. J. Pharm. Biomed. Anal. 37 (2005) 135-142
18. Brenda M., and Gregory G. Biochim. Biophys. Acta Gen. Subj. 1291 (1996) 237-244
19. Embree L., Gelmon K.A., Tolcher A.W., Hudon N.J., Heggie J.R., Dedhar C., Webb M.S., Bally M.B., and Mayer L.D. J. Pharm. Biomed. Anal. 16 (1997) 675-687
20. Gao S.H., Fan G.R., Hong Z.Y., Yin X.P., Yang S.L., and Wu Y.T. J. Pharm. Biomed. Anal. 41 (2006) 240-245
21. The Pharmacopoeia of the People's Republic of China. Part II. The Pharmacopoeia Commission of PRC, 2005, pp. Appendix 174.